Anti-Hemopexin antibody [EPR5610],Abcam,AB124935
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human
Application
WB, IP, Flow Cyt (Intra), IHC-P, ICC/IF
Platform ID
BAB578811446
Abcam
Contact
Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215
Email:
Product Specifications
Scientific Background
Specifications
NameAnti-Hemopexin antibody [EPR5610]
Cat. No.AB124935
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationWB, IP, Flow Cyt (Intra), IHC-P, ICC/IF
ClonalityMonoclonal
Clone NumberEPR5610
Concentration0.11 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine
Storage-20°C
Regulatory StatusResearch Use Only
Scientific Background
Target data Binds heme and transports it to the liver for breakdown and iron recovery, after which the free hemopexin returns to the circulation. See full target information Hemopexin
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
- Products>Primary Antibodies>IHC Antibodies
- Products>Primary Antibodies>Recombinant Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.